Arabin Cervical Pessary

DEVICE4 trials

Sponsors

Hospital Universitari Vall d'Hebron Research Institute, University of Edinburgh, Federico II University, The George Washington University Biostatistics Center

Conditions

Premature BirthPreterm BirthPreterm DeliveryShort CervixTwin Pregnancy With Antenatal Problem

Phase 3

Cervical Pessary in Women With Arrested Preterm Labor and Short Cervix

WithdrawnNCT02849301

Federico II UniversityPreterm Birth

Start: 2016-07-31End: 2018-03-31Updated: 2018-11-19

A Randomized Trial of Pessary in Singleton Pregnancies With a Short Cervix

TerminatedNCT02901626

The George Washington University Biostatistics CenterPreterm Delivery, Short Cervix

Start: 2017-02-14End: 2022-05-10Updated: 2026-06-23

Unknown Phase

The Trial of Pessary After Laser for TTTS

TerminatedNCT01334489

Hospital Universitari Vall d'Hebron Research InstitutePremature Birth

Start: 2012-12-31End: 2020-06-25Updated: 2020-08-27

An Open Randomised Trial of the Arabin Pessary to Prevent Pre-term Birth in Twin Pregnancy

CompletedNCT02235181

University of EdinburghTwin Pregnancy With Antenatal Problem

Start: 2014-11-01End: 2019-10-31Updated: 2020-03-25

Related Papers

The association of sociodemographic differences with clinical management following a diagnosis of short cervix

Pregnancy2026-03-26

Cervical Pessary for Prevention of Preterm Birth in Individuals With a Short Cervix

JAMA2023-07-2539 citations

The Arabin pessary to prevent preterm birth in women with a twin pregnancy and a short cervix: the STOPPIT 2 RCT

Health Technology Assessment2021-07-019 citations

Evaluation of the Arabin cervical pessary for prevention of preterm birth in women with a twin pregnancy and short cervix (STOPPIT-2): An open-label randomised trial and updated meta-analysis

PLoS Medicine2021-03-2950 citations

Open randomised trial of the (Arabin) pessary to prevent preterm birth in twin pregnancy with health economics and acceptability: STOPPIT-2—a study protocol

BMJ Open2018-12-0113 citations

Arabin cervical pessary for prevention of preterm birth in cases of twin-to-twin transfusion syndrome treated by fetoscopic LASER coagulation: the PECEP LASER randomised controlled trial.

2017-08-014 citations